Report: Osteocyte enhancement function of bisphosphonates in prosthetic replacement

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Pharmacology

Background:

• Aseptic loosening is a major cause of joint prosthesis failure, leading to reduced stability and increased revision rates.
• Both mechanical and biological factors contribute to prosthetic loosening.
• Understanding bone metabolism is crucial for improving implant longevity.

Purpose of the Study:

• To elucidate the mechanism of bisphosphonates (BP) in modulating bone metabolism.
• To analyze the action principle and function of BP in prosthetic replacement.
• To evaluate the efficacy of BP in preventing peri-prosthetic bone loss.

Main Methods:

• Review of bisphosphonates' effects on osteocyte function, osteoclast activity, and bone resorption.
• Analysis of animal experimental data and clinical adjuvant therapy in joint replacement patients.
• Evaluation of BP's impact on wear debris-induced osteolysis, stress shielding, and bone density.

Main Results:

• Bisphosphonates enhance osteocyte function, promote new bone formation, and inhibit osteoclast/macrophage resorption activity.
• BP demonstrated efficacy in reducing osteolysis from wear debris, preventing stress shielding, and improving bone density in animal models.
• Clinical application showed BP effectively reduces early peri-prosthetic bone absorption and improves bone mass post-total hip replacement.

Conclusions:

• Bisphosphonates play a vital role in prosthetic replacement by modulating bone metabolism.
• BP is a significant therapeutic choice for preventing peri-prosthetic bone loss after surgery.
• The use of BP can improve long-term outcomes and stability of joint prostheses.